In the past week, IRON stock has gone down by -6.50%, with a monthly decline of -10.19% and a quarterly surge of 11.36%. The volatility ratio for the week is 5.09%, and the volatility levels for the last 30 days are 5.00% for Disc Medicine Inc. The simple moving average for the past 20 days is -7.80% for IRON’s stock, with a 18.60% simple moving average for the past 200 days.
Is It Worth Investing in Disc Medicine Inc (NASDAQ: IRON) Right Now?
The 36-month beta value for IRON is also noteworthy at 0.73. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 4 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for IRON is 15.63M, and at present, short sellers hold a 11.33% of that float. The average trading volume of IRON on January 23, 2025 was 333.78K shares.
IRON) stock’s latest price update
Disc Medicine Inc (NASDAQ: IRON)’s stock price has gone decline by -3.35 in comparison to its previous close of 58.50, however, the company has experienced a -6.50% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-01-22 that WATERTOWN, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the pricing of its upsized underwritten offering of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. Disc is selling 3,918,182 shares of common stock and pre-funded warrants to purchase 181,818 shares of common stock in the offering. The shares of common stock are being sold at an offering price of $55.00 per share, and the pre-funded warrants are being sold at an offering price of $54.9999 per pre-funded warrant, which represents the per share offering price for the common stock less the $0.0001 per share exercise price for each such pre-funded warrant. The aggregate gross proceeds to Disc from this offering are expected to be approximately $225.5 million, before deducting underwriting discounts and commissions and other offering expenses, excluding the exercise of any pre-funded warrants. In addition, Disc has granted the underwriters a 30-day option to purchase up to an additional $33.825 million of shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the securities being sold in the offering are being offered by Disc. The offering is expected to close on January 24, 2025, subject to the satisfaction of customary closing conditions.
Analysts’ Opinion of IRON
Many brokerage firms have already submitted their reports for IRON stocks, with Morgan Stanley repeating the rating for IRON by listing it as a “Overweight.” The predicted price for IRON in the upcoming period, according to Morgan Stanley is $85 based on the research report published on November 05, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see IRON reach a price target of $110, previously predicting the price at $66. The rating they have provided for IRON stocks is “Strong Buy” according to the report published on November 04th, 2024.
Jefferies gave a rating of “Buy” to IRON, setting the target price at $89 in the report published on October 23rd of the previous year.
IRON Trading at -9.90% from the 50-Day Moving Average
After a stumble in the market that brought IRON to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.14% of loss for the given period.
Volatility was left at 5.00%, however, over the last 30 days, the volatility rate increased by 5.09%, as shares sank -13.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.55% lower at present.
During the last 5 trading sessions, IRON fell by -7.37%, which changed the moving average for the period of 200-days by +86.10% in comparison to the 20-day moving average, which settled at $61.29. In addition, Disc Medicine Inc saw -10.82% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IRON starting from Khara Rahul, who sale 7,500 shares at the price of $62.75 back on Jan 02 ’25. After this action, Khara Rahul now owns 14,035 shares of Disc Medicine Inc, valued at $470,658 using the latest closing price.
Quisel John D, the Chief Executive Officer of Disc Medicine Inc, sale 13,012 shares at $61.95 during a trade that took place back on Dec 30 ’24, which means that Quisel John D is holding 72,065 shares at $806,058 based on the most recent closing price.
Stock Fundamentals for IRON
The total capital return value is set at -0.27. Equity return is now at value -25.03, with -23.74 for asset returns.
Based on Disc Medicine Inc (IRON), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -47.06.
Currently, EBITDA for the company is -91.03 million with net debt to EBITDA at 1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.36.
Conclusion
In summary, Disc Medicine Inc (IRON) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
